PIDILITIND - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 4.0
| Stock Code | PIDILITIND | Market Cap | 1,38,840 Cr. | Current Price | 1,364 ₹ | High / Low | 1,575 ₹ |
| Stock P/E | 60.3 | Book Value | 92.8 ₹ | Dividend Yield | 0.73 % | ROCE | 30.5 % |
| ROE | 23.2 % | Face Value | 1.00 ₹ | DMA 50 | 1,387 ₹ | DMA 200 | 1,444 ₹ |
| Chg in FII Hold | -0.26 % | Chg in DII Hold | 0.35 % | PAT Qtr | 607 Cr. | PAT Prev Qtr | 586 Cr. |
| RSI | 47.6 | MACD | 3.13 | Volume | 6,38,901 | Avg Vol 1Wk | 7,89,881 |
| Low price | 1,259 ₹ | High price | 1,575 ₹ | PEG Ratio | 2.95 | Debt to equity | 0.03 |
| 52w Index | 33.2 % | Qtr Profit Var | 13.5 % | EPS | 22.4 ₹ | Industry PE | 29.0 |
📊 PIDILITIND shows strong fundamentals for long-term investment. The company has excellent ROCE (30.5%) and ROE (23.2%), reflecting superior capital efficiency. EPS is ₹22.4, and dividend yield (0.73%) adds modest income appeal. Debt-to-equity is very low (0.03), showing financial stability. The P/E ratio (60.3) is significantly higher than the industry average (29.0), suggesting overvaluation, while PEG ratio (2.95) indicates growth is somewhat expensive. Quarterly PAT improved (₹586 Cr. → ₹607 Cr.), showing earnings momentum, and RSI (47.6) suggests neutral conditions, making current levels attractive for accumulation.
💡 Ideal Entry Price Zone: Accumulation is favorable around ₹1,300–₹1,360, near the recent low (₹1,259) and close to DMA 50 (₹1,387). Current price (₹1,364) is within this zone, offering a reasonable entry point for long-term investors.
📈 Exit Strategy / Holding Period: For existing holders, PIDILITIND is a strong candidate for long-term holding (5+ years) given its efficiency metrics and brand strength. Exit can be considered near ₹1,550–₹1,575 (recent high zone) if valuations stretch without earnings growth. Otherwise, continue holding for compounding benefits supported by strong fundamentals.
Positive
- 📈 ROCE (30.5%) and ROE (23.2%) are very strong.
- 📊 EPS at ₹22.4 reflects profitability.
- 💸 Dividend yield (0.73%) provides modest income.
- 📉 Debt-to-equity ratio (0.03) shows financial stability.
- 📈 PAT improved quarter-on-quarter (₹586 Cr. → ₹607 Cr.).
- 📊 DII holdings increased (+0.35%), showing domestic institutional support.
Limitation
- ⚠️ High P/E (60.3) compared to industry average (29.0).
- 📊 PEG ratio (2.95) indicates growth is expensive.
- 📉 FII holdings decreased (-0.26%), showing reduced foreign investor confidence.
Company Negative News
- 📉 FII holdings declined, reflecting weaker foreign sentiment.
- 📊 Valuations remain stretched relative to industry peers.
Company Positive News
- 📈 PAT growth quarter-on-quarter shows operational improvement.
- 📊 Strong EPS supports valuation comfort.
- 📉 Debt levels remain very low, ensuring financial safety.
Industry
- 🏭 Specialty chemicals/adhesives industry PE is 29.0, much lower than PIDILITIND’s 60.3, suggesting overvaluation.
- 📊 Industry growth remains strong, driven by construction, packaging, and consumer demand.
Conclusion
⚖️ PIDILITIND is fundamentally strong with excellent ROE, ROCE, and a debt-free balance sheet. Despite high valuations and expensive growth metrics, its long-term prospects remain attractive. Ideal entry is near ₹1,300–₹1,360. Existing holders should continue for 5+ years, with exit considered near ₹1,550–₹1,575 if earnings growth slows. Overall, PIDILITIND is a solid candidate for long-term portfolios in the specialty chemicals and adhesives sector.